 Home  About Us  News and Events  Services  Publications  Directorates COVID19

Public Information  Announcement  Contact

Publications Home / Publications

https://t.me/pharmacyh
Filter: Doc Categories  Reset Show All entries

Search:

Title Date

 2024.03.01 Guideline for Registration of Medicine June 14, 2024

 2023.09.06 Guideline-for-WHO-Pre-qualified-Medicines-through- June 14, 2024

Collaborative-Registration-Procedure-

 2023.12.20 GUIDELINE FOR NON-ROUTINE REGISTRATION June 14, 2024

 2023.11.02 Guideline on Variation Application to Registered Medicines June 14, 2024

 2023.12.22 Guidelines on Reliance for Regulatory Decision Making June 14, 2024

 2023.12.21 Guideline on Medical Products Special import permit June 14, 2024

 2024.01.11 Guideline for control of advertising and promotion June 14, 2024

 2024.01.19 Guidance for Registration of Radiopharmaceuticals June 14, 2024

 2024.01.19 Guideline of Medicinal Gases Registration June 14, 2024

 2024.01.20 Guideline for Medicinal product information June 14, 2024

 2024.01.20 Guideline for preparation and publication of public June 12, 2024
assessment reports

 2024.01.20 Guideline for Renewal of MA June 12, 2024

 2024.01.29 Guideline on Variation Applications to Registered Vaccines June 12, 2024 ERROR fo

Invalid do

https://t.me/pharmacyh
Title Date

 2024.01.31 Guidelines for Conditional Approval June 12, 2024

 2024.01.31.Guideline-for-Registration-of-Antiseptics-and-Disinfectants June 12, 2024

 2024.01.31.Guideline-for-Registration-of-oral-care-skin-care-products- June 12, 2024

with-therapeutic-claim

 2024.02.27 Guidance-on-waiver-of-in-vivo-bioequivalence-requirements June 12, 2024

 2024.04.16 Good RevPractice Guideline June 12, 2024

 2024.01.13 Guideline for describing the role and responsibilities of MA June 12, 2024

 2024.01.30 Guidelines for Registration of Biotherapeutic Proteint June 12, 2024

Products

 2024.01.29 Guideline-for-Registration-of-Vaccine June 12, 2024

 2024.01.30 Guidelines on evaluation of similar biotherapeutics June 12, 2024

 1003- ማብራሪያ – የትንባሆ ምርት አወጋገድ መመሪያ ቁጥር 1003-2016 Description May 31, 2024
TOBACCO PRODUCTS DISPOSAL DIRECTIVE 1003-2016

 TOBACCO PRODUCTS DISPOSAL DIRECTIVE 1003-2016 May 31, 2024

 Pharmacovigilance newsletter Q 3 Issue 1_Final__2024 May 31, 2024

 Ethiopian National Tobacco Control Strategic Plan From 2023 – 2031 May 27, 2024

 Sinopharm Covid 19 vaccine active surveillance report April 16, 2024

 EFDA Voice Newsletter April 2024 April 11, 2024

 1000 – የመድኃኒት ማምረቻ ተቋማት የብቃት ማረጋገጫ አሰጣጥ እና ቁጥጥር መመሪያ ቁጥር April 3, 2024
1000-2016

 999 – የመድኃኒት የመልካም አመራረት ሥርዓት ቁጥጥር መመሪያ ቁጥር 999-2016 April 3, 2024

 Rational Drug Use of insulin April 3, 2024

 Rational Drug Use 2 April 3, 2024

 Product Registration April 3, 2024

 Jimma Branch April 3, 2024

 Counterfeit Drugs April 3, 2024


https://t.me/pharmacyh
 Title Date

 Pharmacovigilance newsletter Q 2 Issue 1 March 29, 2024

 Guideline on Variation Applications to Registered Vaccines March 26, 2024

 Guideline of Medicinal Gases Registration March 26, 2024

 Guideline for Renewal of MA March 26, 2024

 Guideline for preparation and publication of public assessment reports March 26, 2024

 Guideline for Non-Routine registration March 26, 2024

 Guideline for Medicinal product information March 26, 2024

 Guideline for describing the role and responsibilities of MA March 26, 2024

 Guidance on waiver of in vivo bioequivalence requirements March 26, 2024

 Guidance for Registration of Radiopharmaceuticals March 26, 2024

 Good RevPractice Guideline March 26, 2024

 Guidelines for Conditional Approval March 26, 2024

 Guideline for Registration of oral care skin care products with therapeutic March 26, 2024
claim

 Guideline-for-Registration-of-Antiseptics-and-Disinfectants March 26, 2024

 Guideline Variation Application to Registered Medicines March 26, 2024

 EFDA Voice Newsletter December 2023 January 16, 2024

 Traditional medicine January 15, 2024

 Tobacco January 15, 2024

 Tobacco control Addis Ababa 3 January 15, 2024

 Tobacco control Addis Ababa 2 January 15, 2024

 Tobacco control Addis Ababa 1 January 15, 2024

 Self medication January 15, 2024

 Seeding trees January 15, 2024

 Press conference January 15, 2024 

https://t.me/pharmacyh
Title Date

 Prescription and non- prescription drug January 15, 2024

 Pharmacovigilance January 15, 2024

 Milk safety January 15, 2024

 Iodized salt January 15, 2024

 Good Dispensing practice January 15, 2024

 Food Adulteration January 15, 2024

 ERIS January 15, 2024

 Anti-microbial resistance January 15, 2024

 Clinical Trial Application Form November 30,

2023

 Routine Clinical Trial Application screening form November 30,

2023

 Non routine clinical trial application screening form November 30,

2023

 Clinical Trial Authorization Guideline (4th edition) October 31, 2023

 EFDA Voice Newsletter September 2023 October 3, 2023

 Overview of barcode use for pharmaceutical products in Ethiopia July 25, 2023

 Identification and Labeling of Pharmaceutical Products with barcode July 25, 2023

 Tenofovir alafenamide fumarate 25 mg _Vemlidy_Gilead Sciences, Inc July 12, 2023

 Sofosbuvir 400 mg and Velpatasvir 100 mg_Epclusa_Gilead Sciences, Inc July 12, 2023

 Emtricitabine and Tenofovir alafenamide fumarate_Descovy 200 mg-25 July 12, 2023
mg _Gilead Sciences, Inc

 Emtricitabine and Tenofovir alafenamide fumarate_Descovy 200 mg-10 July 12, 2023
mg _Gilead Sciences, Inc

 Artemether injection 80 mg_KPC Pharmaceuticals, Inc_SmPC July 12, 2023

 Artemether injection 40 mg_KPC Pharmaceuticals, Inc_SmPC July 12, 2023


https://t.me/pharmacyh
Title Date

 Artemether 20 mg and Lumefantrine 120 mg tablet_Comether_KPC July 12, 2023

Pharmaceuticals, Inc

 Amphotericin B 50mg _AmBisome_Gilead Sciences, Inc. July 12, 2023

 List of Medicines for Community Pharmacy June 9, 2023

 List of Medicines for Drug Shop June 9, 2023

 CEM-ART drugs-2016-2021 June 8, 2023

 A blueprint for strengthening pharmacovigilance systems in resource June 8, 2023

limited countries

 Prevalence, Intensity, and Correlates of Schistosomiasis and Soil- June 8, 2023

Transmitted Helminth Infections after Five Rounds of Preventive
Chemotherapy among School Children in Southern Ethiopia

 Clinical Trial Authorization Guideline June 8, 2023

 Guideline on Medical Products Special import permit June 8, 2023

 Health Policy June 7, 2023

 Guidelines for Registration of Similar Biotherapeutic Products (SBPs) June 7, 2023

 Guidelines for Registration of Biotherapeutic Protein Products June 7, 2023

 Clinical Trial application processing flow diagram June 7, 2023

 List of recalled medicines and medical devices June 7, 2023

 Medicines Waste Management Disposal Directive June 7, 2023

 Report of Pfizer vaccine AEFI in July 2022 June 6, 2023

 Janssen AEFI Active surveillance June 6, 2023

 Efficacy and safety of praziquantel preventive chemotherapy in June 6, 2023

Schistosoma mansoni infected school children in Southern Ethiopia A
prospective cohort study

 COVISHIELD vaccine report June 6, 2023

 Comparative Assessment of the National Pharmacovigilance Systems June 6, 2023

 Baseline assessment of pharmacovigilance June 6, 2023


Title Date

 Adverse Drug Events Reported on DTG June 6, 2023

 ADE-aDSM-Preliminary EFDA June 6, 2023

 MQCD ISO/IEC 17025:2017 June 6, 2023

 Definition of Powers and Duties of the Executive Organs Proclamation June 5, 2023
No. 1263-2021

 Medicine and Medical Device Import, Export and Wholesale Control June 5, 2023
Directive 872-2022

 SUMMARY OF PRODUCT CHARACTERISTICS TEMPLATE FOR Applicants June 5, 2023

 PATIENT INFORMATION LEAFLET (PIL)TEMPLATE FOR Applicants June 5, 2023

 AEFI SURVEILLANCE COURSE FOR HEALTH PROFESSIONALS June 5, 2023

 PV Trainer Guide May 2022 June 5, 2023

 AEFI Training Manual for HCP-EFDA June 5, 2023

 PV Training for Healthcare Professionals Participant’s Manual 2022 June 5, 2023

 list of GCP Inspectors June 4, 2023

 List of GMP inspectors June 4, 2023

 List of pharmaceutical Importer and Wholesaler inspector June 4, 2023

 Guidelines for Consumer Reporting of Side effects of medicines June 4, 2023

 National Pharmacovigilance Guideline June 4, 2023

 TB PV guideline June 2, 2023

 HIV PV guideline June 2, 2023

 Antimalarial PV guideline June 2, 2023

 NTD PV guideline June 2, 2023

 NCD PV guideline June 2, 2023

 EFDA Vaccine Safety Risk and Crisis Communication Guideline June 2, 2023

 EFDA GMP Guideline for pharmaceutical products second edition June 2, 2023

Title Date

 EFDA Voice Newsletter May 2023 May 24, 2023

 EFDA Voice Newsletter December 2022 May 24, 2023

 EFDA Voice Newsletter August 2022 May 24, 2023

 EFDA Voice Newsletter April 2022 May 24, 2023

 GUIDELINE FOR PREPARATION AND PUBLICATION OF PUBLIC May 23, 2023

ASSESSMENT REPORTS FOR APPROVED MEDICINES

 Brochure Results on ADR Reports on DTG containing ARV regimens May 23, 2023

 Magnesium sulfate-Kalceks 500 mg per ml solution for injection_ Public May 17, 2023
assessment summary report_Package label

 OCTANATE 500 and OCTANATE 1000 _SUMMARY OF PRODUCT May 17, 2023
CHARACTERISTICS

 OCTANATE 500 and OCTANATE 1000 _ Public assessment summary May 17, 2023
report

 Utrogestan Vaginal 100 mg and 200 mg Soft capsules _ Public assessment May 17, 2023
summary report_Package label

 Utrogestan Vaginal 100 mg and 200 mg Soft capsules_SUMMARY OF May 17, 2023
PRODUCT CHARACTERISTICS

 Minox 5, 50 mg ml, cutaneous solution_SUMMARY OF PRODUCT May 16, 2023

CHARACTERISTICS

 Minox 5, 50 mg ml, cutaneous solution_ Public assessment summary May 16, 2023
report_Package label

 Delstrigo 100 mg 300 mg 245 mg film-coated tablets_ Public assessment May 16, 2023
summary report_Package label-1

 CELMANTIN 10 mg and 20 mg film-coated tablets_public assessment May 16, 2023

summary report_Package label

 Delstrigo100 mg 300 mg 245 mg film-coated tablets_SUMMARY OF May 16, 2023

PRODUCT CHARACTERISTICS

 CELMANTIN 10 mg and 20 mg film-coated tablets_SUMMARY OF May 16, 2023

PRODUCT CHARACTERISTICS

Title Date

 Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets Summary of product May 15, 2023
Characteristics

 Verquvo 2.5 mg, 5 mg 10 mg film-coated tablets_Public assessment May 15, 2023

summary report and packaging material

 Guideline for Renewal of Medicines Marketing Authorization May 15, 2023

 J&J Vaccine Brochure May 9, 2023

 Medicine Marketing Authorization Directive No. 963-2023 የመድኃኒት የገበያ May 4, 2023
ፈቃድ አሰጣጥ መመሪያ ቁጥር 963-2015

 CLINICAL TRIAL DIRECTIVE No. 964 2023 የህክምና ሙከራ መመሪያ ቁጥር 964- May 4, 2023
2015

 Brochure-MDR medicines aDSM-TICs analysis report April 27, 2023

 Brochure-COVID-19 (Covishield-astrazeneca) vaccine active safety April 27, 2023

monitoring report

 Brochure-Medsafety mobile app for ADR reporting user guide April 27, 2023

 Pfizer Vaccine Brochure April 27, 2023

 Guidelines on Reliance for Regulatory Decision Making April 25, 2023

 Pharmacovigilance newsletter 2015 Q3 March April 24, 2023

 Pharmacovigilance newsletter 2015 Q2 December April 24, 2023

 Pharmacovigilance newsletter 2015 1st quarter April 24, 2023

 Guideline for Emergency use Authorization of Medicines for Public April 3, 2023
Emergency Situations

 Guideline for control of medicine advertising and promotion April 3, 2023

 List of Authorized Clinical Trial Applications V1, 2015 E.C March 10, 2023

 Definition of Organization, Powers and Duties of the Ethiopian Food and March 8, 2023
Drug Authority Council of Ministers Regulation No. 531/2023

 957 Traditional medicinal products Manufacturing Certificate of February 1, 2023

Competence and Market Authorization Directive

 Medicine Donation Control Directive No. 958/2023 February 1, 2023 

Title Date

 Summary of product Characteristics of Sildenafil Citrate 50 January 3, 2023

 Public assessment summary report of sildenafil January 3, 2023

 Pharmacovigilance newsletter Quarter 1 ,Issue 1 Sep, 2022 December 21,

2022

 Pharmacovigilance newsletter Volume 1, Issue 1, 2022 December 21,

2022

 Droxiderm SmPC November 24,

2022

 Droxiderm PAsRv1 November 24,

2022

 Diclofenac Sodium Injection 75 mg/2 ml Public assessment summary November 2,

report 2022

 SUMMARY OF PRODUCT CHARACTERISTICS DICLOFENAC SODIUM November 2,

INJECTION 75MG/2ML 2022

 AEFI standard reporting form Ethiopia October 21, 2022

 Addendum to AEFI Surveillance Guideline 2022 October 21, 2022

 ADE-ADR-ME-reporting form-EFDA October 21, 2022

 AEFI-Surviellance & response of AEFI guideline-3rd edition October 21, 2022

 AEFI-Surviellance & response of AEFI guideline-3rd edition October 19, 2022

 ADE-ADR-ME-reporting form-EFDA October 19, 2022

 Addendum to AEFI Surveillance Guideline 2022 October 19, 2022

 AEFI standard reporting form Ethiopia October 19, 2022

 Pharmacovigilance Directive No. 932/2022 932 የመድኃኒት ጎጂ ባህሪያት ክትትል October 17, 2022
ሥርዓት መመሪያ ቁጥር 932-2015

 Summary of product characteristics for Ritonavir Tablets USP 100 mg October 17, 2022

 Summary of product characteristics for Pyrazinamide 150mg Tablets October 14, 2022

 Summary of product characteristics for DOVPRELA (Pretomanid Tablets October 14, 2022
200 mg) 
Title Date

 Public assessment summary report for DOVPRELA (Pretomanid Tablets October 14, 2022
200 mg)

 Summary of product characteristics for Isoniazid 100mg and 300mg October 10, 2022
tablets

 Public assessment summary report for Isoniazid 100 and 300 mg tablets October 10, 2022

 PRIVACY POLICY October 8, 2022

 Guidelines for Software as Medical Devices September 28,

2022

 Guidelines for Medical Device Refurbishment September 28,

2022

 Guidelines for Medical Device Donations September 16,

2022

 Emergency medicines list September 2,

2022

 OTC medicines list September 2,

2022

 Guidelines for Medical devices Clinical Investigation Authorization July 26, 2022

 Medical devices Decommissioning and Disposal Guideline July 18, 2022

 Medical Devices Recall Guideline July 18, 2022

 Medical devices Post Marketing Surveillance Guideline July 18, 2022

 Guidelines for Medical Devices GMP Inspection May 18, 2022

 Ethiopia’s Medicine and Medicine Facility Inspection Process Achieved May 10, 2022
ISO/IEC 17020:2012 Accreditation

 Pharmaceutical Products Barcoding Guideline May 6, 2022

 Guidelines for Medical device Labeling April 28, 2022

 Hemlibra_Emicizumab_ Summary of product characteristics v1 April 6, 2022

 Hemlibra_Emicizumab_ Public assessment summary reportv1 April 6, 2022


 Title Date

 Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg March 21, 2022

Dispersible_public assessment summary report

 Lumerax DT 20120_ Artemether 20 mg & Lumefantrine 120 mg March 21, 2022

Dispersible_Summary of product characteristics

 የኮቪድ 19 ወረርሽኝ ለመከላከልና ለመቆጣጣር ስለሚወሰዱ ክልከላዎች እና ስለሚጣሉ March 10, 2022
ግዴታዎች ለመወሰን የወጣ መመሪያ ቁጥር 803

 ፕሪከርሰር ኬሚካሎችን ለመቆጣጠር እና በአግባቡ ጥቅም ላይ ለማዋል የወጣ መመሪያ ቁጥር March 10, 2022
393_2012

 ጉድለት የተገኘበት መድኃኒት እና የህክምና መሳሪያ አሰባሰብ መመሪያ ቁጥር_392_2013 March 10, 2022

 በባለስልጣኑ ስር ለሚገኙ የቴክኒክ ኮሚቴዎች የአበል ክፍያ አፈጻጸም መመሪያ 377/2013 March 10, 2022

 የምግብ መድሀኒትና የጤና ክብካቤ አስተዳደርና ቁጥጥር ባለስልጣን የአንድ ጊዜ የመድኃኒት March 10, 2022
ግዢ መመሪያ 374

 የአልኮል ማስታወቂያና ሽያጭ መመሪያ_372_2013 March 10, 2022

 የናርኮቲክ መድኃኒቶችንና የሣይኮትሮፒክ ንጥረ ነገር ማዘዣ ወረቀት ለመቆጣጠር የወጣ መመሪያ March 10, 2022
ቁጥር 369

 የምግብ ጨው ቁጥጥር መመሪያ 361-2013 March 10, 2022

 የምግብ ላኪ፣ አስመጪና አከፋፋይ ቁጥጥር መመሪያ ቁጥር 357_2013 March 10, 2022

 የመድኃኒትና የህክምና መሣሪያ ማስተዋወቅ መመሪያ ቁጥር 353_2013 March 10, 2022

 የመድኃኒት ችርቻሮ ድርጅቶች ቁጥጥር መመሪያ ቁጥር 349_2013 March 10, 2022

 ከጨርቅ የተሰራ የፊት መሸፈኛ ጭንብል አምራች የብቃት ማረጋገጫ የምስክር ወረቀት እና የገበያ March 10, 2022
ፍቃድ 347

 አግባባዊ የመድኃኒት አጠቃቀም ቁጥጥር መመሪያ ቁጥር 346 2013 March 10, 2022

 Administrative Measure Taking and Complaint Handling Directive March 10, 2022
No_345_2013

 Pharmaceutical Manufacturer GMP Inspection Directive No 338 March 10, 2022

 Medical Equipment Donation Directive No. 336-2020 March 10, 2022

 Infant Formula and Follow up Formula Directive No 335 2020 March 10, 2022

 Graphic_Health_Warning_directive_No 334_2013 March 10, 2022 

Title Date

 Food Supplement Directive No. 333-2020 March 10, 2022

 Guidelines for Medical Devices Good Clinical Practices March 8, 2022

 Master data Guideline _2nd Edition 2022 February 7, 2022

 Ethiopian AMR PC_Strategic Plan 2021_2025 February 2, 2022

 Risk Management Plan Guideline for COVID-19 Vaccines January 27, 2022

 General Guidelines for Medical devices Marketing Authorization January 25, 2022

 Guideline on requirements of Medical Devices Clearance at ports of entry January 24, 2022

 Guidelines for Medical Device GDP and GSP January 20, 2022

 Global Trade Item Number (GTIN) Allocation Guideline January 17, 2022

 Global Location Number (GLN) Allocation Guideline January 17, 2022

 GMP Application form December 30,

2021

 INIGAST 40 Public assessment summary report v1 December 15,

2021

 INIGAST 40 Summary of product characteristics v1 December 15,

2021

 ALLTERA 50 Summary of product characteristics v1 December 15,

2021

 ALLTERA 50 Public assessment summary report v1 December 15,

2021

 ALLTERA 50 Public assessment summary report v1 December 14,

2021

 Baby food control directive 840-2021 November 25,

2021

 Guideline for Medical Devices Good Manufacturing Practice November 1,

2021

 Regulatory Preparedness and Mitigation Strategy for Emergency Health October 11, 2021
Threats

 Title Date

 Guidelines for Borderline Medical devices_EFDA October 8, 2021

 Guideline for Registration of Medicines 2020 September 13,

2021

 የመድኃኒት የመልካም አመራረት ስርዓት ቁጥጥር አሰራር መመሪያ 830 2013 September 13,
2021

 Medicine Good Manufacturing Practice (GMP) Inspection Procedure September 13,

Directive 830 2021 2021

 Guideline for Registration of Insecticide Treated Net 2021 August 4, 2021

 Guideline for Classification of In Vitro Diagnostic Medical Devices_EFDA July 21, 2021

 Guideline for Classification of Medical devices other than IVD Medical July 21, 2021
devices_EFDA

 Guideline for Application of Accessories and Spare parts_EFDA July 12, 2021

 Guideline for Medical Devices Bundling for Marketing authorization May 6, 2021
application

 Tobacco Control Directive Number 771/2021 April 20, 2021

 Tobacco Control Directive Number 771/2021 April 20, 2021

 National-pharmacovigilance-Roadmap-2020 April 13, 2021

 Guideline for Medical device Post-approval Change Notification EFDA April 5, 2021

 Guideline for Marketing Authorization of Low risk Medical devices_EFDA April 5, 2021

 Covid-19 vaccine AEFI Reporting Form March 12, 2021

 Covid-19 vaccine AEFI Reporting Form March 12, 2021

 EFDA_Guidelines for IVD Registration Requirements February 19,

2021

 EFDA_Guidelines for Non-IVD Registration Requirements February 19,

2021

 Guideline for COVID-19 Vaccine donation February 15,

2021

 Guidance for Emergency Use Authorization of COVID-19 Vaccine January 29, 2021 
 Title Date

 Traditional Medicine Clinical Trial guidance 2020 November 9,

2020

 Supplementary guideline for Clinical trial Authorization 2020 November 9,

2020

 Guideline for WHO Pre-qualified Medicines through Collaborative October 1, 2020

Registration Procedure

 Guideline for Registration of Low-risk Medicines October 1, 2020

 Risk-based Guideline for Post-Marketing Quality Surveillance September 25,

2020

 Food Consignment Technical guideline September 22,

2020

 PV Newsletter V7 ISSUE 2 Feb 2020 July 8, 2020

 PV Newsletter V7 Issue 1 Oct 2019 July 8, 2020

 Annexes to cosmetic product manufacturing Directive No. 49/2020 June 17, 2020

 Food and Medicine Administration Proclamation No.1112/2019 June 10, 2020

 Internal quality Food import export June 5, 2020

 Traditional Medicine Guidance May 26, 2020

 የኮሮና ቫይረስ ግብአት አምራች፣ አስመጪና አከፋፋይ ድርጅት የብቃት ማረጋገጫ የምስክር April 13, 2020
ወረቀት አሰጣጥ ጊዜያዊ መመርያ

 Temporary COVID-19 Medical Product Approval and Import Permit April 10, 2020
Authorization Directive

 Annexes to Cosmetics Import, Export and Wholesale Control Directive April 1, 2020
No. 48/2020

 Cosmetics Import, Export and Wholesale Control Directive No 331-2020 April 1, 2020

 የኮሮና ቫይረስ ወረርሺኝን ለመከላከል ኅብረተሰቡ የሚጠቀምባቸው የመከላከያ ምርቶች አምራች፣ March 25, 2020
አስመጪ እና አከፋፋይ የብቃት ማረጋገጫ የምስክር አሰጣጥ ጊዜያዊ የአሠራር መመሪያ፡፡ 2012

 Strategy for the Prevention and Containment of AMR in Ethiopia Oct 2015 March 7, 2019

 Strategic plan For Traceability Implementation March 7, 2019


Title Date

 STG -Primary Hospital March 7, 2019

 STG -Health Center March 7, 2019

 STG-General Hospital. March 7, 2019

 Standard operating procedures for pharmaceuticals good distribution March 7, 2019

and storage practices

 RDV Formulary March 6, 2019

 PV NL 8 March 6, 2019

 PV Newsletter VI ISSUE I Nov 2010 March 6, 2019

 PV_Newsletter_V5_ISSUE 3_Dec_2015 March 6, 2019

 PV Newsletter V2 ISSUE 1 Sept 2012 March 6, 2019

 PV Newsletter V2 issue 2 March 6, 2019

 PV Newsletter V1 ISSUE 3 Nov 2011 March 6, 2019

 PV Newsletter V1 ISSUE 2 June 2011 March 6, 2019

 PV Newsletter V5 ISSUE 2 Sep 2015 March 6, 2019

 PV newsletter V3 Issue 4 March 6, 2019

 PV newsletter V3 Issue 1 March 6, 2019

 Proclamation 661 March 6, 2019

 Pharmacovigilance newsletter No 15 March 6, 2019

 Pharmacovigilance newsletter No 10 March 6, 2019

 pharmacovigilance newsletter No 11 March 6, 2019

 pharmacovigilance newsletter no 7 March 6, 2019

 Pharmacovigilance newsletter 16 March 6, 2019

 Pharmacovigilance newsletter 14 March 6, 2019

 Pharmaceutical Assessment 2016 March 6, 2019

 OVER THE COUNTER MEDICINES LIST FOR ETHIOPIA 2nd edition March 6, 2019 
Title Date

 NPS List and report format March 6, 2019

 NPS FORMULARY March 6, 2019

 National Medical Instruments List with minimum specification 2013 March 6, 2019

 Narcotic Manual final March 6, 2019

 Medicines Market Authorization Strategy 2017 March 6, 2019

 Medicines Good Dispensing Manual second edition 2012 March 6, 2019

 Medicine Retail outlet model 2013 March 6, 2019

 Medicine For Ethiopia NDL March 6, 2019

 Medicines Good Prescribing Manual second edition 2012 March 6, 2019

 LIST OF ORPHAN MEDICINES FOR ETHIOPIA 2014 March 6, 2019

 LIST OF MEDICINES FOR RURAL DRUG VENDOR 2011 March 6, 2019

 List of Medicine for Health Centers March 6, 2019

 LIST OF ESSENTIAL MEDICINES FOR ETHIOPIA March 6, 2019

 LDHC March 6, 2019

 Inspection Manual for Inspectors March 6, 2019

 Health Institution Promotion March 6, 2019

 Handbook on Substance Abuse For Trainers March 6, 2019

 Guidelines on evaluation of similar bio-therapeutics March 6, 2019

 Guidelines For Registration Of Medical Devices or Supplies March 6, 2019

 Guidelines for Registration of Bio-therapeutic Protein Products March 6, 2019

 Guideline For Drug Information Center March 6, 2019

 Good prescribing manual for Ethiopia new 2 March 6, 2019

 Good Dispensing manual new 2 March 4, 2019

 GMP Guideliens March 4, 2019


Title Date

 GCP Guideline March 4, 2019

 Finalized_Promotion_Control_guideline_2nd_Edition March 4, 2019

 EXECUTIVE SUMMARY GATS Ethiopia Oct 20 2017 March 4, 2019

 Ethiopia Tobacco Control Strategic Plan March 4, 2019

 Ethiopian Pharma co-vigilance Guideline 2014 March 4, 2019

 Ethiopia_National Drug Control Master Plan 2017 March 4, 2019

 Ethiopia GATS FactSheet Aug 2017 March 4, 2019

 DIB_V5_issue2_new March 4, 2019

 Citizen Charter March 4, 2019

 Bulletin_2007_Issue_1 March 4, 2019

 Bulletin_2006_Issue_3 March 4, 2019

 Bulletin_2006_Issue_2 March 4, 2019

 ART Study March 4, 2019

 AMR Baseline Survey March 4, 2019

 Allergy_card_scan March 4, 2019

 Adverse Drug Event Reporting Form March 4, 2019

 ADR_Study March 4, 2019

 4th_LMDS_List_for_Drug_Shop March 4, 2019

 Medicines Market Authorization Strategy 2017 February 26,

2019

 Rate of service fees regulation no 370 2015 February 26,

2019

 Food Medicine and Healthcare Administration and Control Councils of February 26,
Ministers Regulation No 299 2013 2019

 FCTC Ratification proclamation February 26,

2019

 Title Date

 Guideline for Registration of Vaccine February 26,

2019

 Guideline for Registration of Medical devices 2014 February 26,

2019

 Ethiopian Medicines Formulary 2013 February 26,

2019

 Drug Administration And Control Proclamation No. 176/99 January 8, 2019

 National Drug Policy January 8, 2019

Showing 1 to 353 of 353 entries


OUR VISION Contact Recent News Like Us On
To be a center of Information Facebook
More than 2.7
excellence in food million birr worth of
Address:
and health products Ethiopian Food
Africa Avenue, near illegal drugs, food,
18,978 followers
regulation in Africa. and tobacco
Wolosefer, Kirkos
OUR MISSION sub city, 02/03 products were
kebelle, 02 collected and
Follow Page
To protect and disposed of, along
promote public Business hours:
with food items
health by ensuring Mon - Fri: 8:30 AM -
adulterated with
the safety, 5:30 PM
foreign substances.
effectiveness, quality Phone number: November 7, 2023
and proper use of Tel: +25111-5-
regulated products 524122, Fax: The Hawassa branch
through licensing, +251115521392 & office of the
inspection, +25111552411 E- Authority has
registration, Mail: announced that
laboratory testing, [email protected] more than 1.6
post-marketing thousand tons of
surveillance,    food and more than
community 978 thousand Birr
participation, and worth of drugs and
provision of up-to- medical equipment
date regulatory have been imported
information. into the country in
the past three
months at the
Moyale entry and
exit port.
November 7, 2023

The Ethiopian Food

and Drug Authority
has stated that it will
collaborate with
interested parties to
provide effective
drug safety
monitoring.
May 24, 2023

Copyright © All rights reserved. EFDA.